BullBD Old Apps Site
Home
Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

RENATA

All Eps Dividend Board Agm Q1 Q2 Q3

RENATA 17-Dec-2019

(Continuation news of RENATA): the Hon'ble High Court Division of the Supreme Court of Bangladesh. The Company has also informed that Creditors' meeting date to approve Scheme of Amalgamation of Renata Oncology Limited (Transferor Company) with Renata Limited (Transferee Company) ("the scheme") be and is hereby fixed for February 08, 2020 at 10:30 AM at Renata Limited. (end)

RENATA 17-Dec-2019

(Continuation news of RENATA): The Company has informed that the proposal of Merger and amalgamation (Arrangement and Compromise) of Renata Oncology Limited with Renata Limited as per provision of Section 228 & 229 of the Companies Act, 1994 and the compensation in cash to minority shareholder of Renata Oncology Limited as per net asset value as on June 30, 2019, be and is hereby approved subject to the sanction by (cont.3)

RENATA 17-Dec-2019

(Continuation news of RENATA): Venue: Renata Limited, Plot - 1, Milk Vita Road, Section - 7, Mirpur, Dhaka as per order by the Hon'ble High Court Division of the Supreme Court of Bangladesh in the Company Matter No 285 of 2019 in accordance with the provision of section 228 and 229 of the Companies Act, 1994 for approval of the same scheme by the Members of Renata Limited. Record Date for EGM: 08.01.2020 for shareholders' entitlement to attend the meeting. (cont.2)

RENATA 17-Dec-2019

With reference to their earlier news disseminated by DSE on 14.11.2019, the Company has further informed that pursuant to the order of the Hon'ble court dated December 1, 2019 in the Company matter No 285 of 2019, the Board of Directors of the Company has decided to held an EGM to approve Scheme of Amalgamation of Renata Oncology Limited (Transferor Company) with Renata Limited (Transferee Company). Date of EGM: 08.02.2020, Time: 11:30 AM, (cont.1)

RENATA 17-Dec-2019

The Company has informed that the Board of Directors of the Company has decided to purchase of 173 decimals land at Dogri, Rajendrapur, Gazipur and 136 decimals land at Kandila, Tangail Sadar, Tangail at a cost of Tk. 8.37 crore (approx.) and Tk. 4.76 crore (approx.) respectively including registration and incidental cost. The land will be used for expansion of Ranjendrapur Factory, Gazipur & Depot Office at Tangail.

RENATA 20-Nov-2019

Trading of the Shares of the Company will resume on 21.11.2019 after record date.

RENATA 19-Nov-2019

Trading of the shares of the Company will remain suspended on record date i.e., 20.11.2019 for AGM & EGM.

RENATA 17-Nov-2019

Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefit from 18.11.2019 to 19.11.2019. Trading of the shares of the Company will remain suspended on record date i.e., 20.11.2019 for AGM & EGM.

RENATA 14-Nov-2019

(Continuation news of RENATA): and iii) Approved the draft application of merger of Renata Limited with Renata Oncology Limited for submission to the High Court Division of the Supreme Court of Bangladesh for the amalgamation of these Companies under section 228 read with section 229 of the Companies Act, 1994. (end)

RENATA 14-Nov-2019

(Continuation news of RENATA): subject to approval from the creditors, shareholders and sanction of the High Court Division of the Supreme Court of Bangladesh and other legal/regulatory authorities; ii) Approved the draft Scheme of Amalgamation, with the exchange of 0.02 shares of Renata Limited for each share of Renata Oncology Limited based on Net Asset Value per share as on June 30, 2019, supported by audited financial statements of the two companies; (cont. 2)

Previous Next page